Does systemic inflammation drive endothelial dysfunction and accelerate atherosclerotic plaque progression?

Systemic inflammation is a primary driver of vascular disease, acting through a well-defined mechanistic axis that impairs the inner lining of blood vessels (the endothelium) and accelerates the development of atherosclerosis. This process is particularly relevant in aging populations where chronic low-grade inflammation often intersects with evolving cardiovascular risk profiles.

Mechanistic pathways of vascular impairment

The link between systemic inflammation and endothelial dysfunction is driven by increased oxidative stress and the activation of specific cellular signaling pathways:

• Oxidative stress and NO depletion: Inflammatory cytokines, such as Tumor Necrosis Factor-alpha (TNF-α) and C-reactive protein (CRP), trigger the activation of NADPH oxidase (NOX) enzymes. These enzymes generate excessive reactive oxygen species (ROS), specifically superoxide, which reacts with and neutralizes nitric oxide (NO). This depletion of bioavailable NO—a critical vasodilator and vascular protector—leads to "eNOS uncoupling," where the enzyme responsible for producing NO begins producing more superoxide instead, creating a self-perpetuating cycle of damage.
• Endothelial activation: Inflammatory stimuli activate the NF-κB pathway, a master regulator that shifts the endothelium into a "pro-inflammatory" state. This state is characterized by the increased expression of adhesion molecules like ICAM-1 and VCAM-1, which act as "velcro" for circulating white blood cells (monocytes), encouraging them to stick to and infiltrate the vessel wall.

Clinical evidence and plaque progression

Research confirms that these cellular changes translate directly into measurable vascular damage and plaque growth:

• Impaired vascular function: Clinical studies in patients with chronic inflammatory conditions demonstrate significantly reduced flow-mediated dilation (FMD), a gold-standard measure of how well a vessel can relax. Lower FMD scores are strongly correlated with high levels of systemic markers like CRP.
• Plaque acceleration: Endothelial activation and dysfunction are necessary precursors to atherosclerosis. They facilitate the formation of foam cells and the accumulation of lipids within the vessel wall. Studies using carotid intima-media thickness (cIMT) and coronary artery calcium (CAC) scoring show that markers of endothelial activation (such as E-selectin and IL-6) are significant predictors of increased plaque burden and faster disease progression.

Bottom line

Systemic inflammation promotes endothelial dysfunction by triggering NOX-mediated oxidative stress and NF-κB-driven endothelial activation. These processes reduce nitric oxide bioavailability and increase vascular permeability, directly accelerating the progression of atherosclerotic plaques and increasing overall cardiovascular risk.